About: Susan L Stramer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Susan L Stramer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 研究者 (ja) araştırmacı (tr) дослідник (uk) 研究者 (zh) onderzoeker (nl)
rdfs:label	Susan L Stramer (en) Susan L Stramer (es) Susan L Stramer (nl) Susan L Stramer (ast)
skos:prefLabel	Susan L Stramer (en) Susan L Stramer (es) Susan L Stramer (nl) Susan L Stramer (ast)
name	Susan L Stramer (en) Susan L Stramer (es) Susan L Stramer (nl) Susan L Stramer (ast)
given name	wds:Q66751416-8D56E346-6D15-4D26-93CD-271171EF3EFD
given name	Susan
instance of	wds:Q66751416-6E0B06FB-0D21-46CB-89E0-70AD11844C63
instance of	Homo sapiens
skos:altLabel	Susan Stramer (en)
occupation	wds:Q66751416-93807B13-017D-4AAF-A081-8C1BE4421F1E
sex or gender	wds:Q66751416-f1f7c493-4d4f-cbd7-29d7-67529e3e1648
on focus list of Wikimedia project	wds:Q66751416-E57A5F97-8837-4641-B23E-D8A008192110
family name	wds:Q66751416-F418859A-8341-48E0-BE95-1CA930458817
occupation	researcher
sex or gender	female organism
on focus list of Wikimedia project	WikiProject COVID-19
family name	Stramer
ORCID iD	wds:Q66751416-D8D2653F-3015-42C1-B638-ECA4921BCE89
ORCID iD	https://orcid.org/0000-0002-5865-6366
ORCID iD	0000-0002-5865-6366
is owl:sameAs of	Susan L Stramer
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66751416
is author of	Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA. West Nile virus among blood donors in the United States, 2003 and 2004. Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 Emerging infectious diseases that threaten the blood supply Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker Probable transfusion-transmission of Anaplasma phagocytophilum by leukoreduced platelets Donors deferred for self-reported Chagas disease history: does it reduce risk? Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy Emerging infectious disease agents and their potential threat to transfusion safety Pilot studies for development of an HIV subtype panel for surveillance of global diversity Unifying the spatial epidemiology and molecular evolution of emerging epidemics Chagas disease and the US blood supply Chikungunya virus: possible impact on transfusion medicine Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors Probable and possible transfusion-transmitted dengue associated with NS1 antigen-negative but RNA confirmed-positive red blood cells Zika virus: a new challenge for blood transfusion Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing West Nile virus infections projected from blood donor screening data, United States, 2003 Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005 Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms High levels of subgenomic HCV plasma RNA in immunosilent infections Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in naive and previously vaccinated blood and plasma donors Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Nucleic acid testing to detect HBV infection in blood donors. Evolutionary dynamics of West Nile virus in the United States, 1999-2011: phylogeny, selection pressure and evolutionary time-scale analysis Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission Current risks of transfusion-transmitted agents: a review CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission Sensitivity of HCV RNA and HIV RNA blood screening assays Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006. Dengue virus in blood donations, Puerto Rico, 2005. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010. The safety of the blood supply--time to raise the bar. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. West Nile virus adheres to human red blood cells in whole blood Viral marker rates among blood donors before and after the terrorist attacks on the United States on September 11, 2001.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software